Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company formed to pursue an acquisition in the biotechnology and life sciences sector. The SPAC filed a 10-Q with the SEC on August 11, 2021, accession number 0001213900-21-041642, reflecting its status as an active search-stage vehicle during that period. With a name explicitly tied to the biotech space, BIOT was positioned to target companies in drug development, medical devices, or adjacent life sciences verticals. Sponsor information was not disclosed in the available filing metadata. Visit SpacDesk and sign up for full access to BIOT's complete filing history, sponsor details, and deal-status tracking.